3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
37
NIH
7
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Plasma cell
13
Lymphoid
9
CNS
8
Other hematologic neoplasm
6
Myeloid
3
Sarcoma
2
Other neoplasm
2
Other solid neoplasm
1
Conditions
Sarcoma, Ewing
2
Interventions
Radiotherapy
35
Doxorubicin
30
Ifosfamide
29
Cyclophosphamide
24
Vincristine
23
Filgrastim
23
Etoposide
20
Temozolomide
14
Granulocyte Colony-Stimulating Factor
14
Dactinomycin
11
Cisplatin
11
Trabectedin
10
Methotrexate
10
Gene Expression Profiling
10
Radiation
9
Imatinib Mesylate
9
Surgical Procedures, Operative
8
Polymerase Chain Reaction
8
Irinotecan
8
Specimen Handling
7
Paclitaxel
7
Chemotherapy, Adjuvant
7
Mesna
6
Immunohistochemistry
6
Gemcitabine
6
Carmustine
6
Biopsy
6
sargramostim
5
pegfilgrastim
5
etoposide phosphate
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Melphalan
×
Sarcoma
×
Clear all
NCT02063022
2022-09-19
EW-1
Italian Sarcoma Group
Phase 3
Completed
278 enrolled
NCT02727387
2022-09-19
EW-2
Italian Sarcoma Group
Phase 2
Completed
155 enrolled